Greg Barclay and Professor Frank Deane receiving their IHMRI Clinical Translation Grant. Photo by L.J. Hayes.
IHMRI Clinical Translation Grants bring together academics and clinicians
The Illawarra Health and Medical Research Institute (IHMRI) is proud to announce the recipients of our Clinical Translation Grants (CTG) for 2018.
Part of IHMRI’s annual Grant Program, the CTGs encourage academic, health professional and clinician researchers to co-lead a research project that addresses regional and medically relevant health issues.
“This year we received 12 high-quality applications. Selecting six projects was a difficult process for the Grant Review Committee, but it is very inspiring to see researchers from different fields coming together to address major health challenges in our region,” stated IHMRI Executive Director and CEO, Professor David J. Adams.
“The IHMRI Research Development team is looking forward to working with the recipients to develop the projects for larger external grant applications,” added Research Development Manager, Dr Richard Brown.
Distinguished Professor Antoine van Oijen and Dr Simeon Crawford
Project: Antimicrobial Resistance Global Challenges: the evolving threat and impact to the Illawarra Shoalhaven population—a service utilisation perspective
This project is investigating the threat and challenges of antimicrobial resistance in the Illawarra and Shoalhaven.
The project aims to use the region’s population as a microcosm of the broader Australian community to provide evidence to drive policy and practice changes to improve health outcomes and services.
Dr Natalie Smith and Associate Professor Ping Yu
Project: Pilot trial: Can a mobile health coaching program improve fitness for surgery in patients with obesity?
Every year, 55 per cent of patients who undergo elective surgery at Wollongong Hospital are obese.
This project will investigate the outcomes of a health coaching program to improve fitness for surgery for patients with obesity.
The researchers plan to use smart phones to provide guidance and support to patients to improve their health and reduce their weight during the lead up to surgery.
Dr Jessica Nealon, Professor Victoria Traynor and Nicole Britten
Project: Postoperative delirium in post-anaesthetic care units: Translating knowledge into practice
Postoperative delirium is a major complication of surgery and 80 per cent of cases are misdiagnosed or unrecognised.
This research team will conduct a survey to understand international perspectives about delirium care after operations.
The team will also work with practitioners to develop and trial a sustainable protocol for postoperative delirium care in post-anaesthesia care units.
Professor Frank Deane and Greg Barclay
Project: Assessment and management of distress from breathlessness for patients in palliative care: Benchmarking with clinical practice guidelines
This research team will investigate ways to improve practices for palliative patients experiencing breathlessness.
The aim of the project is to identify and evaluate routine practices currently used to improve inpatient palliative care within the Illawarra Shoalhaven Local Health District (ISLHD).
Dr Kelly Lambert and Associate Professor Anthony Dossetto
Project: From lab bench to clinic room: calcium isotopes as a non-invasive tool for the management of chronic kidney disease
Calcium balance is abnormal in adults with chronic kidney disease (CKD), and is associated with bone loss, blood vessel calcification and increased mortality.
Current methods to manage CKD related bone disease and monitor calcium balance require invasive and expensive testing.
This research team is looking at calcium isotopes as a non-invasive diagnostic tool for the management of CKD in adults.
Dr Daniel Brungs and Dr Kara Vine-Perrow
Project: Circulating tumour necleic acid as a biomarker in resectable gastroesophageal cancer
This project aims to develop new research capabilities in circulating tumour DNA analysis (a rapidly growing field in oncology research) to treat gastroesophageal cancer.
“We aim to use a pilot cohort of 10 patients with previously bio banked specimens to explore the use of ctNA as a biomarker for tumour response, clinical outcomes and detection of remaining disease following targeted surgery,” said Dr Brungs.
Louise Negline, Communications Coordinator
t: 4221 4702
m: 0417 044 867